With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
Daily Mail26d
Ozempic could be prescribed to treat depression - as major study shows weight loss jabs boost mental health
Researchers have found that the slimming jabs—which include blockbusters Wegovy or Ozempic—may have 'an antidepressant effect'. The startling findings raise the possibility that the medicines ...
Ozempic lowers risk of depression — and not because people are happy they’re thinner
Scientists found that patients taking GLP-1RAs reported fewer symptoms of depression than those on the common diabetes drug dipeptidyl peptidase-4 inhibitors (DPP4is), also known collectively as ...
Diabetes.co.uk11d
Retatrutide: How it Works, Evidence, Side Effects
Retatrutide is an new drug that has shown promise in the treatment of obesity and type 2 diabetes. Retatrutide is a type of multi-receptor agonist that targets multiple hormonal pathways involved in ...